Novel imidazolopyrimidines as dual PI3-kinase/mTor inhibitors

被引：0

作者：

Dehnhardt, Christoph ^{[1
]}

Venkatesan, Aranapakam ^{[1
]}

Chen, Zecheng ^{[1
]}

Delos Santos, Efren ^{[1
]}

Santos, Oswaldo ^{[1
]}

Bursavich, Matthew ^{[1
]}

Brooijmans, Natasja ^{[1
]}

Mallon, Robert ^{[1
]}

Hollander, Irwin ^{[1
]}

Feldberg, Larry ^{[1
]}

Lucas, Judy ^{[1
]}

Yu, Ker ^{[1
]}

Ayral-Kaloustian, Semiramis ^{[1
]}

Gibbons, Jay ^{[1
]}

Abraham, Robert ^{[1
]}

Mansour, Tarek ^{[1
]}

机构：

[1] Wyeth Res, Pearl River, NY USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2017

引用

页数：1

共 50 条

[1] Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors
Venkatesan, Aranapakam M.
Dehnhardt, Christoph M.
Chen, Zecheng
Delos Santos, Efren
Dos Santos, Osvaldo
Bursavich, Matthew
Gilbert, Adam M.
Ellingboe, John W.
Ayral-Kaloustian, Semiramis
Khafizova, Gulnaz
Brooijmans, Natasja
Mallon, Robert
Hollander, Irwin
Feldberg, Larry
Lucas, Judy
Yu, Ker
Gibbons, Jay
Abraham, Robert
Mansour, Tarek S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 653 - 656
[2] Novel imidazolopyrimidines as dual Pl3-kinase/ mTor inhibitors
Dehnhardt, Christoph
Venkatesan, Aranapakam
Chen, Zecheng
Delos Santos, Efren
Santos, Oswaldo
Bursavich, Matthew
Brooijmans, Natasja
Mallon, Robert
Hollander, Irwin
Feldberg, Larry
Lucas, Judy
Yu, Ker
Ayral-Kaloustian, Semiramis
Gibbons, Jay
Abraham, Robert
Mansour, Tarek
CANCER RESEARCH, 2009, 69
[3] Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
Cho, Daniel C.
Mier, James W.
CURRENT CANCER DRUG TARGETS, 2013, 13 (02) : 126 - 142
[4] Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform
Staben, Steven T.
Ndubaku, Chudi
Blaquiere, Nicole
Belvin, Marcia
Bull, Richard J.
Dudley, Danette
Edgar, Kyle
Gray, Daniel
Heald, Robert
Heffron, Timothy P.
Jones, Graham E.
Jones, Mark
Kolesnikov, Aleks
Lee, Leslie
Lesnick, John
Lewis, Cristina
Murray, Jeremy
McLean, Neville J.
Nonomiya, Jim
Olivero, Alan G.
Ord, Rachel
Pang, Jodie
Price, Stephen
Prior, Wei Wei
Rouge, Lionel
Salphati, Laurent
Sampath, Deepak
Wallin, Jeff
Wang, Lan
Wei, BinQing
Weismann, Christian
Wu, Ping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2606 - 2613
[5] A dual PI3-kinase/mTOR inhibitor reveals emergent efficacy in glioma
Fan, QiWen
Knight, Z. A.
Goldenberg, D. D.
Wei, Y.
Mostov, K. E.
Stokoe, D.
Shokat, K. M.
Weiss, W. A.
ANNALS OF NEUROLOGY, 2006, 60 : S114 - S114
[6] Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
Ghareghomi, Somayyeh
Atabaki, Vahideh
Abdollahzadeh, Naseh
Ahmadian, Shahin
Ghoran, Salar Hafez
ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (01) : 24 - 35
[7] Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma
Kirstein, Martha M.
Boukouris, Aristeidis E.
Pothiraju, Deepika
Buitrago-Molina, Laura E.
Marhenke, Silke
Schuett, Jutta
Orlik, Johanna
Kuehnel, Florian
Hegermann, Jan
Manns, Michael P.
Vogel, Arndt
LIVER INTERNATIONAL, 2013, 33 (05) : 780 - 793
[8] Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
Hassan, Burhan
Akcakanat, Argun
Holder, Ashley M.
Meric-Bernstam, Funda
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (04) : 641 - +
[9] Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
Proud, CG
CARDIOVASCULAR RESEARCH, 2004, 63 (03) : 403 - 413
[10] Small Molecule Inhibitors of the PI3-Kinase Family
Knight, Zachary A.
PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2, 2011, 347 : 263 - 278

← 1 2 3 4 5 →